8-KLeadership ChangesExhibits & Filings

DANAHER CORP /DE/ 8-K Report, Executive Changes (Jun 29, 2022)

Filed June 29, 2022For Securities:DHR

Summary

Danaher Corporation (DHR) announced on June 28, 2022, a change to its Board of Directors. The size of the Board has been increased from thirteen to fourteen members with the appointment of Feroz Dewan. Mr. Dewan's term will extend until the 2023 annual meeting of shareholders, and he has been assigned to the Science & Technology Committee. As a non-employee director, Mr. Dewan will be compensated in line with other independent directors, including an annual equity award, as previously disclosed in their Form 10-K. He has also entered into a standard director indemnification agreement. The company has confirmed that Mr. Dewan meets the independence requirements of the New York Stock Exchange, and there are no undisclosed related-party transactions or understandings influencing his appointment.

Key Highlights

  • 1Danaher's Board of Directors size increased from 13 to 14 members.
  • 2Feroz Dewan appointed as a new independent director.
  • 3Mr. Dewan will serve until the 2023 annual shareholders meeting.
  • 4Appointed to the Science & Technology Committee of the Board.
  • 5Compensation for Mr. Dewan as a non-employee director will be in line with existing policies, including an annual equity award.
  • 6Mr. Dewan has entered into a director indemnification agreement.
  • 7The company has confirmed Mr. Dewan's independence per NYSE listing standards.

Frequently Asked Questions

Feroz Dewan's appointment increases the Board's size and brings new expertise, particularly with his placement on the Science & Technology Committee, which could influence strategic decisions related to innovation and research and development.

As a non-employee director, Mr. Dewan will receive compensation consistent with other independent directors, which includes an annual equity award. Specific details are available in Danaher's 2021 Form 10-K.

While his appointment to the Science & Technology Committee suggests a focus on innovation, this filing does not provide specific details on any impending strategic shifts. Investors should monitor future communications and earnings calls for further insights.

The filing explicitly states there are no arrangements or understandings with other persons regarding his selection, nor are there any transactions requiring disclosure under Item 404(a) of Regulation S-K, indicating no apparent conflicts of interest at the time of appointment.